Acute human immunodeficiency virus infection in a breast-fed infant in New York City

Pediatric Infectious Disease Journal

Volumn 26, Issue 7, 2007, Pages 653-655

  Nicholson, Ouzama ^a   Michalik, David E ^a   Patel, Sameer ^a   LaRussa, Philip ^a   Neu, Natalie ^a  

^a New York Presbyterian Hospital ^*  (United States)

Author keywords

Acute HIV infection; Breast feeding; Cytomegalovirus; Mother to child transmission; Pneumocystis carinii pneumonia

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CORTICOSTEROID; COTRIMOXAZOLE; GANCICLOVIR; IMMUNOGLOBULIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE;

ADD ON THERAPY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BRAIN DISEASE; BREAST FEEDING; CASE REPORT; CHICKENPOX; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE SWELLING; FEMALE; FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INFANT; LUMBAR PUNCTURE; LUNG VENTILATION; PANCYTOPENIA; PERINATAL PERIOD; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; RHINORRHEA; SEROCONVERSION; SORE THROAT; TREATMENT DURATION; VERTICAL TRANSMISSION; VIRUS CULTURE; VIRUS LOAD; WESTERN BLOTTING;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BREAST FEEDING; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; ENCEPHALITIS, VIRAL; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INFANT; NEW YORK CITY; PNEUMONIA, PNEUMOCYSTIS;

EID: 34347342844     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e3180616ca5     Document Type: Article

References (23)

1. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180.
2. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med. 2004;351:217-228.
3. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, et al. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA. 2001;285:2083-2093.
4. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484-494.
5. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clin Infect Dis. 2005;40:458-465.
6. Magder LS, Mofenson L, Paul ME, et al. Risk factors for in utero and intrapartum transmission of HIV. J Acquir Immune Defic Syndr. 2005;38:87-95.
7. Wade NA, Zielinski MA, Butsashvili M, et al. Decline in perinatal HIV transmission in New York State (1997-2000). J Acquir Immune Defic Syndr. 2004;36:1075-1082.
8. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA. 2001;285:709-712.
9. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000;283:1167-1174.
10. Gray RH, Li X, Kigozi G, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366:1182-1188.
11. Chirgwin KD, Feldman J, Dehovitz JA, Minkoff H, Landesman SH. Incidence and risk factors for heterosexually acquired HIV in an innercity cohort of women: temporal association with pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20:295-299.
12. ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstet Gynecol. 2004;104:1119-1124.
13. Sansom SL, Jamieson DJ, Farnham PG, Bulterys M, Fowler MG. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission. Obstet Gynecol. 2003;102:782-790.
14. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep. 1995;44:1-15.
15. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339:33-39.
16. Daar ES, Little S, Pitt J, et al. Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network. Ann Intern Med. 2001;134:25-29.
17. Lavreys L, Thompson ML, Martin HL Jr, et al. Primary human immunodeficiency virus type 1 infection: clinical manifestations among women in Mombasa, Kenya. Clin Infect Dis. 2000;30:486-490.
18. Rouet F, Sakarovitch C, Msellati P, et al. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics. 2003;112:e289.
19. Abrams EJ, Weedon J, Steketee RW, et al. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis. 1998;178:101-108.
20. Chakraborty R, Morel AS, Sutton JK, et al. Correlates of delayed disease progression in HIV-1-infected Kenyan children. J Immunol. 2005;174:8191-8199.
21. Dunn D. Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet. 2003;362:1605-1611.
22. Rouet F, Elenga N, Msellati P, et al. Primary HIV-1 infection in African children infected through breastfeeding. AIDS. 2002;16:2303-2309.
23. Kinomoto M, Appiah-Opong R, Brandful JA, et al. HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors. Clin Infect Dis. 2005;41:243-251.